Navigation Links
Kaiser Permanente CEO Receives Diversity Leadership Award
Date:11/1/2007

OAKLAND, Calif., Nov. 1 /PRNewswire/ -- Kaiser Permanente Chairman and Chief Executive Officer George Halvorson was among eight chief executives who received the CEO Diversity Leadership Award from the Diversity Best Practices organization at their Diversity and Inclusion Leadership Summit & Gala on November 1, 2007. Halvorson also delivered the keynote speech on diversity initiatives in the health care sector.

Halvorson was recognized for the personal passion for diversity he has brought to his leadership at Kaiser Permanente. "As CEO, George Halvorson combines the rare qualities of first-hand diversity knowledge, personal diversity commitment, and purposeful action to integrate diversity into critical aspects of our business and organizational culture," said Ronald Knox, Kaiser Permanente Vice President and Chief Diversity Officer, who introduced Halvorson at the awards ceremony. "He leads diversity by example and holds himself and his senior executive colleagues accountable for results. He has raised the bar for CEO diversity leadership."

Kaiser Permanente is a national leader in diversity programs and has successfully translated its diversity into better quality for patients through its culturally competent care and linguistics programs, as well as effective marketing, workforce diversity, and community outreach.

Kaiser Permanente was named one of the Top 50 Companies for Diversity by DiversityInc magazine in 2007 and 2006. It has received a 100% rating on the Corporate Equality Index by the Human Rights Campaign for the past three years, and it was awarded the Recognizing Innovation in Multicultural Health Care Award by the National Committee for Quality Assurance.

In selecting the award winners, the Diversity Best Practices Leadership Award Committee nominates those CEOs who are leading organizations that they have determined are "best in class" diversity leaders based on rigorous CEO diversity leadership standards and criteria.<
'/>"/>

SOURCE Kaiser Permanente
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...1.4% Shareholders Intend To Vigorously Protect Inv...INCINNATI, Nov. 21 Dr. ...filed an amendment to their Schedule 13D with the ...p previously filed a 13D disclosing ownership of 1...operates 77 LasikPlus fixed-site laser vision corr...
(Date:11/21/2008)...RANKLIN LAKES, N.J., Nov. 21 /PRNewswire-FirstCall...e for medical intervention in treating 88 percent ...percent of Americans treated for a chronic conditi... spending and 75 percent of all medical costs. A ...e years by Medco Health Solutions, Inc. (NYSE: M...
(Date:11/21/2008)...xperiments in mice find running increases producti... 21 (HealthDay News) -- In experiments in mice, ex...ction of brain stem cells usually seen with aging,...e restoration of the brain,s ability to stave off ...estore a neurochemical that is essential for the p...
(Date:11/21/2008)...EW YORK, Nov. 21 /PRNewswire/ -- For the second... years , McCann Healthcare Worldwide,s agency net...y network at the 22nd annual international RX Club...e agency offices won a total of 59 RX Club Awards ...e winning McCann Healthcare Worldwide agencies inc...
Breaking Medicine News(10 mins):Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Exercise Keeps the Brain Young 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4
...which is synonymous with children and yummy cereal...els that they are using unfair marketing practices...g the company and Viacom that runs Nickelodeon cha... had been sent to Kellogg and Viacom saying it wou...
...le libido can be increased by drinking coffee, acc... University who carried out experiments on rats. C...ch is involved in regulating arousal. // This effe...the beverage regularly, as it was seen in the expe...
... and heart diseases can be triggered by stress at ...ducted by the University College London (UCL). The...lth has also been identified by the study.// There...c syndrome and stress among the 10,000 civil serva...
...went on strike after a clash between Uttar Pradesh...were returning after writing PG Medical Entrance i...ing medicos and eight police recruits. //The clash...cupying the reserved seats of the medicos. The Me...
Other Medicine News:
(Date:11/19/2008)...e/ -- Posit Science Corporation,researcher, Dan T...science,Annual Conference in Washington, DC this ...it Baby Boomers. The computerized brain plasticit...exercises that target auditory and,language syste...ed,improvements in cognition by improving speed a...
(Date:11/19/2008)... statistical significance , , ISELIN, N.J.,...ation (Nasdaq: PARS ) today announced results fr...Emulsion (NE) drug delivery technology formulated ...multi-center, randomized, double-blinded, placebo-... of the Company,s 3% Diclofenac Diethanolamine Nan...
(Date:11/19/2008)...wswire/ -- Biotech scientists increasingly are app... to better understand the effects of novel drug ca...enetic Engineering & Biotechnology News ( GEN... a new compound,s mechanism of action and eventual...ccording to the November 15 issue of GEN . ( http...
(Date:11/19/2008)... Roche- , , MONTVALE, N.J., Nov. 19 /PRNews...asdaq: MEMY ) today announced that it has achiev...487/MEM 3454, its lead alpha-7 nicotinic receptor ...chizophrenia (CIAS). The Company has randomized 2...0 million payment from its partner Roche. Memory ...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Nasal spray using bodys immune system provides hope of cure for common cold 22508 1ASTRO The Wellness Community Greater Boston Join to Promote Cancer Survivorship 22505 1ASTRO The Wellness Community Greater Boston Join to Promote Cancer Survivorship 22505 2AMDL Announces Guidance for FY2008 22502 1AMDL Announces Guidance for FY2008 22502 2AMDL Announces Guidance for FY2008 22502 3AMDL Announces Guidance for FY2008 22502 4AMDL Announces Guidance for FY2008 22502 5Lockheed Martin Wins 2424 Million IT Contract With CDC 22499 1Lockheed Martin Wins 2424 Million IT Contract With CDC 22499 2
...ad Genetics Presents Studies Characterizing Vascul..., N.Y., April 20, 2007 /PRNewswire-FirstCall/ --,E...racterizing a,dual mode of action for Azixa(TM), a...cs, Inc. for the treatment of primary and,secondar...ng of the,American Association of Cancer Research ...
... Announces Positive Top-Line Phase III Results for...et Seizures in,Paediatric Patients from One Month ... - April 20, 2007 - UCB today announced,positive t...ndomized, multi-centre, placebo-controlled study e...reg; (levetiracetam) (20-50,mg/kg/day) as adjuncti...
Other Medicine Technology:Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR 2Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR 3Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR 4Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR 5UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: